Hyaluronic acid and albumin based nanoparticles for drug delivery
- PMID: 33503486
- DOI: 10.1016/j.jconrel.2021.01.033
Hyaluronic acid and albumin based nanoparticles for drug delivery
Abstract
Albumin, a multifunctional protein, is widely used to prepare nanocarriers. Hyaluronic acid (HA) is a natural glycosaminoglycan that can specifically bind receptors, such as cluster of differentiation-44. Therefore, HA is commonly used as ligands for the surface modification of versatile nanocarriers. The combined utilization of albumin and HA as nanocarriers shows outstanding superiorities including efficient targeting, reducible particle size, pH and/or hyaluronidase sensitive drug release, combining capacity for various drugs, biocompatibility, non-immunogenicity, biodegradability and high stability. However, to the best of our knowledge, HA and albumin based nanoparticles have not been reviewed for drug delivery so far. This review involves the introduction of the essential information of HA and albumin as well as a brief presentation of the preparation methods of HA and albumin based nanocarriers. Moreover, the application of HA and albumin based nanoparticles as drug delivery carriers in tumors, joints, vitreum and skin tissue is systematically discussed with the potential and prospect in combined therapy and theranostics. In addition, the unique advantages of the HA and albumin based nanoparticles and their contributions to the improvement of drug delivery systems are further expounded in detail.
Keywords: Albumin; Combined therapy; Drug delivery; Hyaluronic acid; Nanoparticle; Theranostics.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
Research Progress of Hyaluronic Acid-Coated Nanocarriers in Targeted Cancer Therapy.Cancer Biother Radiopharm. 2025 May;40(4):231-243. doi: 10.1089/cbr.2024.0143. Epub 2024 Nov 29. Cancer Biother Radiopharm. 2025. PMID: 39611654 Review.
-
Enzyme/GSH/pH-responsive hyaluronic acid grafted porous silica nanocarriers bearing Ag2S QDs for fluorescence imaging and combined therapy.Carbohydr Polym. 2023 Apr 1;305:120547. doi: 10.1016/j.carbpol.2023.120547. Epub 2023 Jan 6. Carbohydr Polym. 2023. PMID: 36737216
-
A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles.Carbohydr Polym. 2019 Mar 15;208:356-364. doi: 10.1016/j.carbpol.2018.12.074. Epub 2018 Dec 23. Carbohydr Polym. 2019. PMID: 30658811 Review.
-
Exploring the applications of hyaluronic acid-based nanoparticles for diagnosis and treatment of bacterial infections.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Jul;14(4):e1799. doi: 10.1002/wnan.1799. Epub 2022 Apr 29. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022. PMID: 35485247 Free PMC article. Review.
-
Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.Acta Biomater. 2018 Oct 15;80:364-377. doi: 10.1016/j.actbio.2018.09.006. Epub 2018 Sep 8. Acta Biomater. 2018. PMID: 30201431
Cited by
-
Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204.Cells. 2022 Sep 29;11(19):3065. doi: 10.3390/cells11193065. Cells. 2022. PMID: 36231028 Free PMC article.
-
CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction.Mol Med. 2022 Dec 3;28(1):145. doi: 10.1186/s10020-022-00575-5. Mol Med. 2022. PMID: 36463112 Free PMC article.
-
Biomaterials in Drug Delivery: Advancements in Cancer and Diverse Therapies-Review.Int J Mol Sci. 2024 Mar 8;25(6):3126. doi: 10.3390/ijms25063126. Int J Mol Sci. 2024. PMID: 38542103 Free PMC article. Review.
-
Optimizing the Biocompatibility of PLLA Stent Materials: Strategy with Biomimetic Coating.Int J Nanomedicine. 2024 Jun 4;19:5157-5172. doi: 10.2147/IJN.S462691. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38855731 Free PMC article.
-
Hyaluronic Acid Modified Metal Nanoparticles and Their Derived Substituents for Cancer Therapy: A Review.Pharmaceutics. 2023 Jun 12;15(6):1713. doi: 10.3390/pharmaceutics15061713. Pharmaceutics. 2023. PMID: 37376161 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources